CTOs on the Move

Terns Pharmaceuticals

www.ternspharma.com

 
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ternspharma.com
  • 1065 East Hillsdale Boulevard Suite 100
    Foster City, CA USA 94404
  • Phone: 650.275.4395

Executives

Name Title Contact Details

Funding

Terns Pharmaceuticals raised $30M on 04/03/2018
Terns Pharmaceuticals raised $80M on 10/30/2018
Terns Pharmaceuticals raised $87M on 01/05/2021

Similar Companies

BlueWind Medical

Agadia

Agadia is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ReCept Pharmacy

ReCept Pharmacy is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cetylite Industries Inc

Cetylite Industries Inc is a Pennsauken, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Provident Research

Provident Research is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.